Literature DB >> 24810633

QPEEG analysis of the effects of sodium valproate on adult Chinese patients with generalized tonic-clonic seizures.

Jiamei Guo1, Dan Wang, Min Ren, Bo Xiong, Zengyou Li, Xuefeng Wang, Kebin Zeng.   

Abstract

Objectives EEG effects of the sustained-release form of sodium valproate (SR-VPA) are unknown, although it is widely used in Chinese patients with generalized tonicclonic seizures (GTCS). Methods Fourteen newly diagnosed, untreated GTCS patients were recruited and treated with SR-VPA. Waking EEG was recorded and analyzed by way of quantitative pharmaco-electroencephalogram (QPEEG) analysis during the three-month follow-up. Results There was a statistically significant decrease in the absolute power of the delta band (P < 0.05), theta band (P < 0.03) and partial alpha-1 band (p < 0.05) with treatment compared to before treatment, while there was no significantly different absolute power between one-month and three-months after treatment. There was a strong correlation between the decrease in absolute power and the degree of the initial abnormality in all frequency bands. Two of 14 patients experienced seizures during the second month after initiation of SR-VPA therapy. Conclusions SR-VPA selectively decreased the activity of the abnormal EEG synchronization in a use-dependent manner. The reduced theta, delta, and partial alpha-1 absolute power may reflect or confirm the efficacy of SR-VPA on patients with GTCS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24810633     DOI: 10.1007/s11011-014-9561-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  23 in total

Review 1.  Cognitive side effects of antiepileptic drugs.

Authors:  Pavel Ortinski; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2004-02       Impact factor: 2.937

2.  Another nail in the coffin.

Authors:  Eileen Pg Vining
Journal:  Epilepsy Curr       Date:  2010-05       Impact factor: 7.500

3.  Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.

Authors:  Jounhong Ryan Cho; Dae Lim Koo; Eun Yeon Joo; So Mi Yoon; Eunji Ju; James Lee; Dae Young Kim; Seung Bong Hong
Journal:  Clin Neurophysiol       Date:  2011-10-13       Impact factor: 3.708

Review 4.  New perspectives in pharmaco-electroencephalography.

Authors:  Andrew A Fingelkurts; Alexander A Fingelkurts; Seppo Kähkönen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-12-19       Impact factor: 5.067

5.  Distribution of spatial complexity of EEG in idiopathic generalized epilepsy and its change after chronic valproate therapy.

Authors:  Istvan Kondakor; Marton Toth; Jiri Wackermann; Csilla Gyimesi; Jozsef Czopf; Bela Clemens
Journal:  Brain Topogr       Date:  2005-12-05       Impact factor: 3.020

6.  IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN committee. International Federation of Clinical Neurophysiology.

Authors:  M R Nuwer; D Lehmann; F Lopes da Silva; S Matsuoka; W Sutherling; J F Vibert
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1994-07

7.  Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy.

Authors:  J O Willoughby; S P Fitzgibbon; K J Pope; L Mackenzie; A V Medvedev; C R Clark; M P Davey; R A Wilcox
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 8.  Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system.

Authors:  D Cotariu; J L Zaidman; S Evans
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

9.  Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.

Authors:  Kebin Zeng; Xuefeng Wang; Zhiqing Xi; Yong Yan
Journal:  Clin Neurol Neurosurg       Date:  2010-01-13       Impact factor: 1.876

10.  Valproate decreases EEG synchronization in a use-dependent manner in idiopathic generalized epilepsy.

Authors:  Béla Clemens
Journal:  Seizure       Date:  2007-08-13       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.